🇺🇸 FDA
Patent

US 8846686

Compounds useful as inhibitors of ATR kinase

granted A61KA61K31/4745A61K31/497

Quick answer

US patent 8846686 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K31/4745, A61K31/497, A61K31/7068, A61K33/243